Gynecology & Obstetrics

Gynecology & Obstetrics
Open Access

ISSN: 2161-0932

Case Report - (2015) Volume 5, Issue 12

Cervical Adenocarcinoma In situ Presentation of the Case and Review of Incidence, Recurrence Rate and Therapeutic Options

Tokatlidou Zoi* and Panagou Paraskeui
Private Practice, Mitropoleos 101 Thessaloniki, Greece
*Corresponding Author: Tokatlidou Zoi, Private Practice, Mitropoleos 101 Thessaloniki, Greece, Tel: + 2310288118 Email:

Abstract

Cervical adenocarcinoma in situ (AIS) is a Adenocarcinoma in situ of the cervix (AIS) is a premalignant lesion that was first described by Helper in 1952 in his review of adenocarcinoma of the cervix.The following year Friedal reported two women who had undergone therapy for squamous cervical lesions and had concomitant cervical AIS.These authors postulated that this glandular lesion was a precursor to invasive adenocarcinoma similar to preinvasive squamous cell carcinoma in situ. An increase in the incidence of cervical AIS has been reported in recent years. In this fact may contributed an increased prevalence of HPV18, the pathologist’s awareness of the lesion and an increase in use of oral contraceptives.

Keywords: Cervix; Adenocarcinoma in situ; Glandular dysplasia; Invasive aden`ocarcinoma

Introduction

Cervical adenocarcinoma in situ (AIS)

Adenocarcinoma in situ of the cervix (AIS) is a premalignant lesion that was first described by Helper in 1952 in his review of adenocarcinoma of the cervix [1]. The following year Friedal reported two women who had undergone therapy for squamous cervical lesions and had concomitant cervical AIS [2]. These authors postulated that this glandular lesion was a precursor to invasive adenocarcinoma similar to preinvasive squamous cell carcinoma in situ. An increase in the incidence of cervical AIS has been reported in recent years [3-5]. In this fact may contributed an increased prevalence of HPV 18, the pathologist’s awareness of the lesion and an increase in use of oral contraceptives.

Diagnosis and pathogenesis

The diagnosis of cervical AIS seems to be difficult and most of the time occurs as an incidental finding in a specimen of a cone biopsy or cervical cone excision coexistent with cervical squamous lesion. When lesion of glandular epithelium is reported in a smear test the following steps are suggested: colposcopy –biopsy–endocervical curretage and cold knife cone of the cervix in order to define the margins, the depth of the lesion and excluding the invasive cervical cancer. The incidence of cervical AIS it has been estimated to be in the range of 1/8000 to 1/475.000.In several studies that we reviewed [6,7,8-13] 85%-100% papanicolaou tests were abnormal. Lee et al. calculated the sensitivity of Papanicolaou tests for cervical adenocarcinoma in situ to be from 55% to 72% [14]. The results of the endocervical curretage performed in women with AIS were reported on 185 patients in six studies [9-11,12,15,16,17]. The false negative rates ranged from 10% to 67% with an overall rate of 48% [9-12,15]. The pathogenesis of cervical AIS has not been completely delineated. On the other hand squamous cell carcinoma in situ has been well studied and the progression of dysplasia to invasive disease is very clear defined. The rare incidence of AIS makes very difficult the delineation of natural history of glandular dysplasia which could consist the precursor of cervical AIS [18-25].

Presentation of our case report and therapeutic approach

Our patient woman of age 36 years old came to our private medical office for a second opinion after having a second pathological smear test and a cervical biopsy which results were discordant with the results of smear test. The patient reported that she was following regular annual gynaecological screening exams and she had normal smear tests from 2007 until 2010 when the results showed cervicitis. She reported that she was suggested from her gynaecologist to repeat the smear test after 6 months. On 23/09/2010 the new smear test showed ASGUS and was suggested colposcopy and cervical biopsy was held without any pathological finding. Antibiotic treatment was given and cryopexy was made .Finally was suggested to repeat the smear test after 6 months. On 10/03/2011 thin prep was made and the results were CIN 1-2.Cervical biopsy followed again and the results showed glandular dysplasia. We don’t have a clear information if second cryopexy was made but next thin prep reveled CIN 2-3 (HGSL) with possible involvement of glandular epithelium. With all these results that women provided to us our first thought was that the biopsies were’t taken from the proper place as long as the thin prep results insisted for the lesions. The women from her obstetrical history had one normal labor 8 years ago free personal history and no family history. Her gynaecological examination revealed cervix of a parous woman with transformation zone clearly visible, uterus and ovaries appeared normal by transvaginal ultrasound. Colposcopy was made -the transformation zone appeared very clear with an exophytic lesion on 7th o’ clock position of the cervix on the glandular epithelium with high vascularization from the 7th to 12:00 o’ clock position. From the squamous epithelium didn’t appear any serious lesion.A small loop cervical excision was made and we removed the lesion and the sublesional stroma with possible diagnosis of exophytic condylomatous lesion of cervix and we sent it for histological examination. The histological exam showed adenocarcinoma in situ well differentiated and CIN 1/HPV of squamous epithelium. We followed endocervical and endometrium curretage with negative for a disease results. Then large cold knife cone was made 4×3, 6×2, 5 cm. The histological examination showed adenocarcinoma in situ of endocervix from 6 o clock position until 12:00 o’clock position. No invasive disease reported. The glandular dysplastic lesions reached the border of excision at 10:00 o’clock position. We discussed with the patient the need to repeat new cervical cone excision and also the rates of recurrence of the disease and so finally was decided total hysterectomy without salpingo oophorectomy. The histological specimen of uterus and cervix showed glandular dysplasia from 6 to 12:00 o clock position, multilayered epithelium,medium nuclear atypia and mitotic divisions. The surgical margins of excisionof cervix was free of glandular dysplasia. Histological results showed: glandular dysplasia of endocervical epithelium. Follow up of the patient until today is clear of disease. In (Figure 1) below we summarize the management of AIS.

gynecology-obstetrics-Cervical-conization-adenocarcinoma

Figure 1: Cervical conization adenocarcinoma in situ (no invasive cancer).

Summary

The incidence of cervical adenocarcinoma in situ is increasing in frequency although very few cases has been described in the literature. The residual disease rates are as high as 80% when the cervical cone margins are positive which signifies the necessity gynecologist and pathologists to become familiar with these cases. Therapeutic options depending on the age of involved women and the desire for fertility preservation. We discuss and describe a case report of adenocarcinoma of cervix in situ coexistent with glandular dysplasia with no invasive disease.

Conclusions

International literature reviewing showed two different approaches of the patient with cervical AIS .Recent reviews reported increasing in number of patient who undergone cold knife cervical cone with free of disease surgical margins having a good follow up. Very good prognosis in relation with the rate of reccurence of disease. The rate of recurrence of disease is wide from 0% to 44%. (Table 2) shows the results of several studies according to disease recurrence after conservative management. Therefore the decision of conservative therapy depends on the age and the desire of the women to preserve fertility. In women with free of disease surgical margins of cervical excision and negative endocervical curretage the cervical cone must be cover all the transformation zone and to have at least 25 mm of depth. The patient must be reliable for regular follow up every three to six months for International literature reviewing showed two different approaches of the patient with cervical AIS .Recent reviews reported increasing in number of patient who undergone cold knife cervical cone with free of disease surgical margins having a good follow up. Very good prognosis in relation with the rate of reccurence of disease. The rate of recurrence of disease is wide from 0% to 44%. (Table 2) shows the results of several studies according to disease recurrence after conservative management. Therefore the decision of conservative therapy depends on the age and the desire of the women to preserve fertility. In women with free of disease surgical margins of cervical excision and negative endocervical curretage the cervical cone must be cover all the transformation zone and to have at least 25 mm of depth. The patient must be reliable for regular follow up every three to six months for the next two years. Women with positive surgical margins of cervical excision are not candidates for conservative therapy because of the high incidence of residual disease 55,2% and 7,7% of invasive cervical cancer (Wolf et al.[10]).Therefore diagnosis of adenocarcinoma in situ in women of young age with desire of fertility preserving must be followed by conservative therapy when they fulfill the proper criteria (repeat conization until we have negative margins). There is no reason for conservative therapy when childbearing has been completed. In this case method of first choise is total hysterectomy with bilateral salpingooophorectomy after the exclusion of invasive disease. The high rate of recurrence of disease signifies the need of regular follow up in patient of cervical adenocarcinoma in situ independently of the therapy. (Table 1) below shows the results of several studies we found in literature about the residual disease and cone biopsy margin status.

  Residual disease  
  Negative Positive
 Author Margins Margins
Poynoret al. [16] 4/10 (40%) 3/8 (38%)
Hopkins et al. [17] 1/7 (14%) 4/5 (80%)
Wildrichet al. [7] 0/3 (0%) 9/14 (64%)
Denehyet al. [9] 2/7 (29%) 7/10 (70%)
Wolf et al. [10] 7/19 (37%) 10/21 (48%)
Goldstein et al. [11] 13/43 (30%) 8/18 (44%)
Bertrand et al. [15] 0/4 (0%) 0/3 (0%)
Imet al. [18] 4/9 (44%) 5/6 (83%)
Anderson and Arffmann [12]  (12) 0/4 (0%) 2/4 (50%)
Nicklinet al. [20] 2/11 (18%) 5/11 (46%)
Ostoret al. [19] 2/8 (25%) 9/12 (75%)
Azodiet al. [23] 5/16 (31%) 9/16 (56%)
Cullimoreet al. [25] * 1/8 (13%)
Shin et al. [8] 1/16 (6%) 13/21 (61%)

*Negative endocervical margins patients were managed with cone biopsy.

Table 1: Residual disease and cone biopsy margin status.

Author No of patients treated conservatively Recurrence
Bertrand et al. [15] 5 0
Poynoret al. [16] 15 7
Hopkins et al. [17] 3 0
Wildrichet al. [7] 38 6
Denehyet al. [9] 19 1
Wolf et al. [10] 6 2
Anderson and Arffman [12] 23 0
Imet al. [18] 2 0
Ostoret al. [19] 53 0
Nicklinet al. [20] 12 0
Lueslyet al. [21] 7 1
Houghton et al. [22] 11 0
Azodiet al. [23] 8 1
Shin et al. [8] 95 9
Total 297 27 (9%)

Table 2: Disease recurrence after conservative management.

References

  1. Hepler TK, Dockerty MB,Randall LM(1952) Primary adenocarcinoma of the cervix. Am J ObstetGynecol 63: 800-808.
  2. Friedell GH, McKay DG (1953) Adenocarcinoma in situ of the endocervix. Cancer 6: 887-897.
  3. Wright TC,Richart RM (1997)Pathogenesis and diagnosis of preinvasive lesions of the lower genital tract.Principles and Practice of Gynaecologic Oncology,New York 675-715.
  4. Wright TC, Kurman RJ, FerenczyA (1994) Precancerous lesions of the cervix. In:Kurman RJ,ed.Blausteins Pathology of the female genital tract. 4th ED.New York229-277.
  5. Jaworski RC, Pacey NF, Greenberg ML, Osborn RA (1988) The histologic diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri. Cancer 61: 1171-1181.
  6. Christopherson WM, NealonN, Gray LA (1979) Noninvasive precursor lesions of the adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer 44: 975-983.
  7. Widrich T, Kennedy AW, Myers TM, Hart WR, Wirth S (1996) Adenocarcinoma in situ of the uterine cervix:Management and outcome .GynaecolOncol 61: 304-308.
  8. Shin CH, Schorge JO, Lee KR, Sheets EE (2000) Conservative management of adenocarcinoma in situ of cervix. GynaecolOncol 69: 6-10.
  9. Denehy TR, Gregori CA, Breen JL (1997) Endocervicalcurretage,cone margins ,and residual adenocarcinoma in situ of the cervix. ObstetGynaecol 90:1-6.
  10. Wolf JK,Levenback C, Malpica A, Morris M, Burke T, et al. (1996) Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. ObstetGynecol 88: 82-86.
  11. Goldstein NS, Mani A (1998) The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ. Am J ClinPathol 109; 727-732.
  12. Anderson ES, Arffmann E (1989) Adenocarcinoma in situ of the uterine cervix ;Aclinico-pathologic study of 36 case. GynaecolOncol 35: 1-7.
  13. Tobón H, Dave H (1988) Adenocarcinoma in situ of the cervix. Clinicopathologic observations of 11 cases. Int J GynecolPathol 7: 139-151.
  14. Lee KR, Minter LJ, Granter SR (1997) Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases. Am J ClinPathol 107: 30-35.
  15. Bertrand M, Lickrish GM, Colgan TJ (1987) The anatomic distribution of cervical adenocarcinoma in situ: Implications for treatment. Am J ObstetGynecol 157: 21-25.
  16. Poynor EA,Barakat RR, Hoskins WJ (1995) Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. GynecolOncol 57: 158-164.
  17. Hopkins MP, Roberts JA, Schmidt RW (1988) Cervical adenocarcinoma in situ. ObstetGynecol 71: 842-844.
  18. Im DD, Duska LR, Rosenshein NB (1995) Adequasy of conization margins in adenocarcinoma in situof the cervixas a predictor of the residual disease. GynecolOcol 59: 179-182.
  19. Ostör AG, Pagano R, Davoren RA, Fortune DW, Chanen W, et al. (1984) Adenocarcinoma in situ of the cervix. Int J GynecolPathol 3: 179-190.
  20. Nicklin JL, Wright RG, Bell JR, Samaratunga H, Cox NC, et al. (1991) Aclinicopathological study of adenocarcinoma in situ of the cervix. The influence of cervical HPV infection and other factors, and the role of conservative surgery. Aust N Z J ObstetGynaecol 31: 179–183.
  21. Luesly DM, Jordan JA, Woodman CBJ, Watson N, Williams DR, et al. (1987) A retrospective review of adenocarcinoma in situ and glandular atypia of the uterine cervix.Br J ObstetGynaecol 94: 699-703.
  22. Houghton SJ,Shafi MI, Rollason TP, Luesley DM (1997) Is loop excision adequate primary management of adenocarcinoma in situ of the cervix? Br J ObstetGynaecol 104: 325-329.
  23. Azodi M, Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, et al. (1999) Adenocarcinoma in situ of the cervix: management and outcome. GynecolOncol 73: 348-353.
  24. Weisbrot IM, Stabinsky C, Davis AM (1972) Adenocarcinoma in situ of the uterine cervix. Cancer 29: 1179-1187.
  25. Cullimore JE,Luesley DM, Rollason TP, Waddell C, Williams DR (1989) A case of glandular intraepithelial neoplasia involving the cervix and vagina. GynecolOncol 34: 249-252.
Citation: Zoi T, Paraskeui P (2015) Cervical Adenocarcinoma in situ Presentation of the Case and Review of Incidence, Recurrence Rate and Therapeutic Options. Gynecol Obstet (Sunnyvale) 5:342.

Copyright: © 2015 Zoi T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top